A Prospective comparative study of the 1-year dental implant treatment success between well-controlled diabetic and healthy patient: A randomized clinical trial
- Conditions
- Healthy (ASA II classification)Age ≥18 yearsIn diabetes group,HbA1c level is does not exceed 8%Patient requires replacement of maxillary premolar or molar edentulous area with implant,which
- Registration Number
- TCTR20201216002
- Lead Sponsor
- one
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 20
Healthy (ASA II classification)
Age ≥18 years
In diabetes group, HbA1c level is does not exceed 8%
Patient requires replacement of maxillary premolar or molar edentulous area with implant, which has history of extraction at least 6 months.
Normal occlusion
Normal psychological condition.
No smoking
Good cooperation with available appointment and follow clinician’s instruction
Accept process of the study and sign consent form
Adequate keratinised tissue at least 4 mm.
Appropriate size of edentulous ridge with at least 6 mm in width and 12 mm in height
No bone augmentation at surgery site
Pregnant or breastfeeding period
On NSAID or immunosuppressive drug
Osteoporosis
HIV
Diabetes patient with major complication, such as cardiovascular, peripheral vascular, nervous system and nephrotic system
History of head and neck chemotherapy and radiotherapy
Anterior and third molar edentulous area
HbA1c level above 8%
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Implant stability quotient every week after dental implant placement use magnetic device to evaluate micro-movement
- Secondary Outcome Measures
Name Time Method satistraction 1 year after using dental implant questionnaires,clinical dental movement 1 year after using dental implant oral observation,inflammation 1 year after using dental implant oral observation